The Cohorts · Quarterly vintage
Inception 2026-01-01 · 0.7 years held
Q1 2026 · Top 20.
On 2026-01-01, these 20 businesses were the 20most-undervalued names in our coverage universe by Mr. Market's protocol. We've held them, equal-weighted, since.
Q1 2026 · Top 20 · since inception
+4.4%
CAGR 6.2% annualised
S&P 500 · since inception
+12.6%
CAGR 18.0% annualised
Spread
-8.2%
This cohort has trailed the index.
Other cohorts at the same inception
The constituents.
Ranked, on the inception date, by Δ% to intrinsic value. Each holding is equal-weighted at 5.0% of the portfolio.
| Rank | Ticker | Entry price | Entry IV | Entry Δ% | Current price | Return | Contribution | |
|---|---|---|---|---|---|---|---|---|
| 1 | OXY | $40.55 | $373.46 | +821.0% | $58.84 | +45.1% | +2.3% | Read → |
| 2 | ADBE | $349.99 | $1,326.50 | +314.4% | $248.92 | -28.9% | -1.4% | Read → |
| 3 | META | $658.91 | $2,312.22 | +250.9% | $665.75 | +1.0% | +0.1% | Read → |
| 4 | UNH | $323.71 | $991.73 | +206.4% | $376.90 | +16.4% | +0.8% | Read → |
| 5 | UNP | $227.87 | $625.21 | +174.4% | $279.37 | +22.6% | +1.1% | Read → |
| 6 | CAT | $569.39 | $1,538.67 | +170.2% | $808.99 | +42.1% | +2.1% | Read → |
| 7 | PG | $140.19 | $364.17 | +159.8% | $146.39 | +4.4% | +0.2% | Read → |
| 8 | GOOGL | $312.39 | $809.50 | +159.1% | $349.54 | +11.9% | +0.6% | Read → |
| 9 | NKE | $62.07 | $160.08 | +151.3% | $35.51 | -42.8% | -2.1% | Read → |
| 10 | V | $348.62 | $873.04 | +150.4% | $368.29 | +5.6% | +0.3% | Read → |
| 11 | MA | $568.09 | $1,356.53 | +138.8% | $565.24 | -0.5% | -0.0% | Read → |
| 12 | LOW | $237.47 | $613.45 | +132.2% | $192.49 | -18.9% | -0.9% | Read → |
| 13 | CVX | $148.27 | $343.82 | +131.9% | $209.51 | +41.3% | +2.1% | Read → |
| 14 | PEP | $139.28 | $311.90 | +123.5% | $129.75 | -6.8% | -0.3% | Read → |
| 15 | MSFT | $480.57 | $1,054.72 | +119.5% | $493.78 | +2.7% | +0.1% | Read → |
| 16 | JNJ | $203.67 | $447.47 | +119.1% | $269.99 | +32.6% | +1.6% | Read → |
| 17 | COST | $858.55 | $1,821.65 | +106.5% | $895.31 | +4.3% | +0.2% | Read → |
| 18 | WMT | $110.71 | $231.00 | +95.1% | $106.73 | -3.6% | -0.2% | Read → |
| 19 | MCD | $299.75 | $574.60 | +91.7% | $248.24 | -17.2% | -0.9% | Read → |
| 20 | ORCL | $193.05 | $344.55 | +73.1% | $147.61 | -23.5% | -1.2% | Read → |
Biggest contributors
Where the cohort earned its keep.
- OXY · $40.55 → $58.84+45.1%
- CAT · $569.39 → $808.99+42.1%
- CVX · $148.27 → $209.51+41.3%
Biggest detractors
Where the protocol got it wrong.
- NKE · $62.07 → $35.51-42.8%
- ADBE · $349.99 → $248.92-28.9%
- ORCL · $193.05 → $147.61-23.5%